Literature DB >> 1741162

Overexpression of c-met proto-oncogene but not epidermal growth factor receptor or c-erbB-2 in primary human colorectal carcinomas.

C Liu1, M Park, M S Tsao.   

Abstract

The epidermal growth factor receptor (EGFR) and the protein products of c-erbB-2 and c-met proto-oncogenes belong to a family of growth factor receptors with tyrosine kinase activity. In human colonic carcinomas, the expression of the EGFR and c-erbB-2 have been studied at the protein level only, while c-met expression has not been reported. We have examined the mRNA expression of these genes in human normal colorectal mucosa and primary carcinomas. The results demonstrate that the normal mucosa shows highly variable levels of EGFR and c-erbB-2 mRNAs, but expresses consistently low amounts of c-met mRNA. Colorectal carcinomas did not express significantly higher levels of the EGFR and c-erbB-2 mRNAs than the normal mucosa. In contrast, c-met was consistently and significantly overexpressed (mean sixfold) in carcinomas as compared with normal mucosa. Seventy percent of paired normal-tumor specimens showed a tumor to normal c-met mRNA ratio of greater than 4. The expression of c-met mRNA was also enhanced in the adenomas, suggesting that over-expression of this proto-oncogene may have mechanistic significance in the early stages of human colorectal carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1741162

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  47 in total

1.  The tyrosine phosphatase SHP-2 is required for sustained activation of extracellular signal-regulated kinase and epithelial morphogenesis downstream from the met receptor tyrosine kinase.

Authors:  C R Maroun; M A Naujokas; M Holgado-Madruga; A J Wong; M Park
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

2.  An overview of the c-MET signaling pathway.

Authors:  Shawna Leslie Organ; Ming-Sound Tsao
Journal:  Ther Adv Med Oncol       Date:  2011-11       Impact factor: 8.168

3.  HGF/SF increases tumor blood volume: a novel tool for the in vivo functional molecular imaging of Met.

Authors:  Galia Tsarfaty; Gideon Y Stein; Sharon Moshitch-Moshkovitz; Dafna W Kaufman; Brain Cao; James H Resau; George F Vande Woude; Ilan Tsarfaty
Journal:  Neoplasia       Date:  2006-05       Impact factor: 5.715

4.  Plasma hepatocyte growth factor levels are increased in systemic inflammatory response syndrome.

Authors:  M Sakon; Y Kita; T Yoshida; K Umeshita; M Gotoh; T Kanai; T Kawasaki; J Kambayashi; M Monden
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

5.  Enhanced transformation by a plasma membrane-associated met oncoprotein: activation of a phosphoinositide 3'-kinase-dependent autocrine loop involving hyaluronic acid and CD44.

Authors:  D M Kamikura; H Khoury; C Maroun; M A Naujokas; M Park
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

Review 6.  Colon cancer and the epidermal growth factor receptor: Current treatment paradigms, the importance of diet, and the role of chemoprevention.

Authors:  Baldeep Pabla; Marc Bissonnette; Vani J Konda
Journal:  World J Clin Oncol       Date:  2015-10-10

7.  Alterative expression of the collagenase and adhesion molecules in the highly metastatic clones of human colonic cancer cell lines.

Authors:  Y Nakayama; K Okazaki; K Shibao; T Sako; K Hirata; N Nagata; M Kuwano; H Itoh
Journal:  Clin Exp Metastasis       Date:  1998-07       Impact factor: 5.150

8.  Hepatocyte growth factor (HGF/SF) is expressed in human epithelial cells during embryonic development; studies by in situ hybridisation and northern blot analysis.

Authors:  Y Wang; C Selden; S Farnaud; D Calnan; H J Hodgson
Journal:  J Anat       Date:  1994-12       Impact factor: 2.610

9.  Purification of total RNA from human stool samples.

Authors:  R J Alexander; R F Raicht
Journal:  Dig Dis Sci       Date:  1998-12       Impact factor: 3.199

10.  Expression of growth factor receptor-encoded mRNA by colonic epithelial cells is altered in inflammatory bowel disease.

Authors:  R J Alexander; A Panja; E Kaplan-Liss; L Mayer; R F Raicht
Journal:  Dig Dis Sci       Date:  1995-03       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.